Phase 2 Basket Study of Tucatinib in Combination with Trastuzumab in Subjects with Previously Treated, Locally-Advanced Unresectable or Metastatic Solid Tumors Driven by HER2 Alterations

Administered By

Awarded By

Contributors

Start/End

  • September 1, 2020 - November 30, 2025